Dimensional Fund Advisors LP Cuts Stock Position in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Dimensional Fund Advisors reduced its Acadia Healthcare stake by 7.3% in the first quarter, selling 202,892 shares and retaining 2.58 million shares worth approximately $60.4 million.
• Analyst sentiment improved, with Jefferies and Raymond James upgrading the stock and several firms raising price targets; however, the overall consensus remains “Hold” with an average target of $29.85.
• Acadia reported quarterly EPS of $0.38, exceeding the $0.35 estimate, while revenue of $865.8 million also surpassed expectations. Revenue declined 0.4% year over year, and the company guided to fiscal 2026 EPS of $1.45–$1.60.

Dimensional Fund Advisors LP decreased its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 7.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,581,747 shares of the company's stock after selling 202,892 shares during the quarter. Dimensional Fund Advisors LP owned about 2.81% of Acadia Healthcare worth $60,384,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the stock. Parallel Advisors LLC raised its position in Acadia Healthcare by 857.8% in the first quarter. Parallel Advisors LLC now owns 6,858 shares of the company's stock valued at $160,000 after purchasing an additional 6,142 shares during the period. Bank of New York Mellon Corp grew its stake in shares of Acadia Healthcare by 1.8% in the first quarter. Bank of New York Mellon Corp now owns 483,950 shares of the company's stock valued at $11,320,000 after buying an additional 8,790 shares in the last quarter. Principal Financial Group Inc. grew its stake in shares of Acadia Healthcare by 27.4% in the first quarter. Principal Financial Group Inc. now owns 558,486 shares of the company's stock valued at $13,063,000 after buying an additional 120,197 shares in the last quarter. Teachers Retirement System of The State of Kentucky raised its holdings in shares of Acadia Healthcare by 5.1% during the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 75,095 shares of the company's stock valued at $1,757,000 after buying an additional 3,642 shares during the period. Finally, Fifth Third Bancorp lifted its position in Acadia Healthcare by 11,144.0% during the 1st quarter. Fifth Third Bancorp now owns 25,299 shares of the company's stock worth $592,000 after acquiring an additional 25,074 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Jefferies Financial Group raised shares of Acadia Healthcare from a "hold" rating to a "buy" rating and raised their price target for the company from $24.50 to $30.00 in a report on Wednesday, June 3rd. Raymond James Financial upgraded shares of Acadia Healthcare from an "outperform" rating to a "strong-buy" rating and set a $39.00 price objective on the stock in a report on Monday, May 4th. Royal Bank Of Canada upped their price objective on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an "outperform" rating in a research report on Monday, May 4th. Barclays raised their target price on Acadia Healthcare from $25.00 to $32.00 and gave the company an "equal weight" rating in a research note on Thursday. Finally, UBS Group raised their price objective on Acadia Healthcare from $31.00 to $39.00 and gave the company a "buy" rating in a research note on Thursday, July 9th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Acadia Healthcare presently has an average rating of "Hold" and an average target price of $29.85.

Acadia Healthcare Stock Performance

ACHC stock opened at $29.62 on Friday. The stock's 50 day simple moving average is $28.23 and its 200 day simple moving average is $23.74. Acadia Healthcare Company, Inc. has a 12-month low of $11.43 and a 12-month high of $35.83. The firm has a market cap of $2.76 billion, a P/E ratio of -2.38, a P/E/G ratio of 9.84 and a beta of 0.64. The company has a current ratio of 1.57, a quick ratio of 1.71 and a debt-to-equity ratio of 1.20.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.03. The firm had revenue of $865.84 million during the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The firm's revenue was down .4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, equities research analysts predict that Acadia Healthcare Company, Inc. will post 1.54 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.